Other substances

Sar9, Met (O2)11-Substance P

A neurokinin-1 receptor agonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Sar9, Met (O2)11-Substance P on PubChem

Synonyms

Bhsar-SP

 

Structure image - Sar9, Met (O2)11-Substance P

CC(C)C[C@@H](C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)N)NC(=O)CN(C)C(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCN=C(N)N)N

Supporting references

Link Tested on Impact factor Notes Publication date
Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)
Spike protein ACE2 Peptide In silico 		in silico 2.74

Predicted to bind human ACE2 receptor at its interface with SARS-CoV-2 Spike protein.

 Jan/08/2021
Export (.csv)